PreveCeutical Provides Update on Research Program for Development of Non-Addictive Analgesics Cannabis Investing News
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO Pharmaceutical Investing
Reata Announces Clinical Trial Design for FALCON a Phase 3 Trial of Bardoxolone Methyl Pharmaceutical Investing
Constellation Pharmaceuticals Provides Update on MANIFEST Clinical Trial of CPI-0610 Life Science Investing
Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck Pharmaceutical Investing
